Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Global Scars Pipeline Review 2016 - Research and Markets

Research and Markets
Posted on: 06 Oct 16

Research and Markets has announced the addition of the "Scar - Pipeline Review, H2 2016" report to their offering.

Scar pipeline therapeutics constitutes close to 24 molecules, out of which approximately 21 molecules are developed by Companies and the remaining by Universities/Institutes. Our latest report Scar - Pipeline Review, H2 2016, outlays comprehensive information on the therapeutics under development for Scars, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.

A scar is a permanent patch of skin that grows over a wound. Scars occur at the site of tissue damage and appear as firm red-to-purple fibrous tissue that over time usually becomes flatter and lighter in color. The molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 3, 1, 15 and 1, respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 2 and 1 molecules, respectively.

Furthermore, this report also reviews key players involved in therapeutic development for Scars and features dormant and discontinued projects.

Key Topics Covered:

  1. Introduction
  2. Scars Overview
  3. Therapeutics Development
  4. Pipeline Products for Scars - Overview
  5. Pipeline Products for Scars - Comparative Analysis
  6. Scars - Therapeutics under Development by Companies
  7. Scars - Therapeutics under Investigation by Universities/Institutes
  8. Scars Products Glance
  9. Late-Stage Products
  10. Clinical-Stage Products
  11. Early-Stage Products
  12. Scars - Products under Development by Companies
  13. Scars - Products under Investigation by Universities/Institutes
  14. Scars - Companies Involved in Therapeutics Development
  • 3M Drug Delivery Systems
  • Albireo AB
  • Altacor Limited
  • Beech Tree Labs, Inc.
  • Clanotech AB
  • Escape Therapeutics, Inc.
  • FirstString Research, Inc.
  • LegoChem Biosciences, Inc.
  • Moerae Matrix, Inc.
  • Promore Pharma
  • RXi Pharmaceuticals Corporation
  • VBS Pharmaceuticals

For more information about this report visit

View source version on

Business Wire

Last updated on: 06/10/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.